1. Home
  2. Analysis of incidence and prevalence of the respiratory system diseases of the adult population of Moscow and the Russian Federation

Analysis of incidence and prevalence of the respiratory system diseases of the adult population of Moscow and the Russian Federation

PDF (Русский)
Отправить по e-mail Связаться с автором Цитировать
URL
https://www.city-healthcare.com/index.php/magazine/article/view/108
DOI:
https://doi.org/10.47619/2713-2617.zm.2022.v3i1;6-15
Authors
Viktoriya M. Kuraeva, Svetlana I. Feiginova, Anastasia M. Podchernina
Institutions
Research Institute of Healthcare Organization and Medical Management of the Moscow Healthcare Department
Issue
Vol. 3 No. 1 (2022): Archive
Published
2022-04-10
Pages
6-15
Section
Original Researches
Keywords:
incidence , prevalence, noncommunicable diseases, chronic lower respiratory diseases, asthma, chronic obstructive pulmonary disease, adult population, Moscow, Russia

Abstract

Introduction. As a result of the COVID-19 pandemic that swept the whole world in 2020, the level and structure of morbidity changed, the “center of gravity” of adult mortality shifted towards infectious diseases. The anti-epidemic reorientation of healthcare systems in the world has had a negative impact on the health of patients with non-communicable diseases (NCDs). As a result, the morbidity of the adult population, in particular respiratory diseases related to the most important NCDs, becomes particularly relevant in the conditions of epidemiological restrictions in Moscow with the spread of the COVID-19 and the increased burden on the Healthcare system of Moscow.

Purpose. The purpose of this study is to analysis of indicators of incidence and prevalence of the respiratory system diseases of the adult population of Moscow and the Russian Federation for the periods 2015–2019 and 2019–2020.

Methods and materials. The study used data of the official statistics of the Ministry of Health of the Russian Federation of the “Morbidity of the Russian population” (incidence and prevalence by the care seeking data) for 2015–2020, by the ICD-10 chapter X “Diseases of the respiratory system” (J00-J99), blocks “Chronic lower respiratory diseases” (J40-J47): Asthma, Status asthmaticus (J45, J46); Other chronic obstructive pulmonary disease (J44); chronic bronchitis, Emphysema (J40-J43).

Results. The respiratory system diseases continue to occupy leading positions in the structure of morbidity of the adult population of Moscow and the Russian Federation. In the structure of the prevalence of the adult population of Moscow in 2020, respiratory system diseases accounted for 16.8 % (in 2015 – 15.1 %), which is lower than in the whole of the Russian Federation – 17.7 % (2015 – 13.8 %). In the structure of the incidence of the adult population of Moscow was 33.8% (in 2015 – 33.5 %), which is lower than in the whole of the Russian Federation, amounting to 36.9 % (2015 – 28.2 %).

The prevalence the respiratory system diseases of the adult population of respiratory system diseases in 2020 in Moscow was 20 830.8 per 100 000 population, which is 19.6 % lower than in the whole of the Russian Federation (25 910.0). Over the period 2015–2019, the indicator of prevalence tended to increase in Moscow by 10.2 %, in the Russian Federation – by 6.2 %. For the period 2019–2020 in Moscow, the increase was only 5.4 %, in the Russian Federation there were higher growth rates (+21.9 %).

The incidence the respiratory system diseases in 2020 in Moscow was 15,832.1 per 100 000 population, which is 1.3 times lower than the national average (21,376.0). Over the period 2015–2019, the incidence rate decreased in Moscow by 7.9 %, in the Russian Federation – by 6.6 %. In 2019–2020, the growth rate in Moscow was 4.8 %, in general, a higher increase of 29.7 % was recorded in the Russian Federation.

For the period from 2015 to 2019 and during the period of “COVID-19 lockdowns” in 2020, mainly in Moscow, there are high rates of increase in the incidence of chronic obstructive pulmonary disease and asthma. At the same time, a decrease in the level of prevalence and incidence of chronic bronchitis and emphysema was registered both in Moscow and in the Russia.

Conclusion. Thus, the morbidity of the adult population the diseases of respiratory system in Moscow tends to decrease, while in the Russian Federation to increase, which requires additional research to find cause-and-effect relationships.

Полный текст

Author Biographies

Viktoriya M. Kuraeva, Research Institute of Healthcare Organization and Medical Management of the Moscow Healthcare Department analyst

Svetlana I. Feiginova, Research Institute of Healthcare Organization and Medical Management of the Moscow Healthcare Department analyst

Anastasia M. Podchernina, Research Institute of Healthcare Organization and Medical Management of the Moscow Healthcare Department Head of Center for Medical Statistics

Список литературы

  1. Kontsevaia AV, Myrzamatova AO, Mukaneeva DK, Sapunova ID, Balanova IuA, Khudiakov MB., et al. The economic burden of main non-communicable diseases in the Russian Federation in 2016. Profilakticheskaya Meditsina. 2019; 22(6): 18-23. doi: 10.17116//profmed20192206118 (In Russ.).
  2. Asthma – WHO Fact sheets [Online]. URL: https://www.who.int/ru/news-room/fact-sheets/detail/asthma (cited 2022 Apr 14). (In Russ.).
  3. Chronic obstructive pulmonary disease (COPD) – WHO Fact sheets [Online]. Available from: https://www.who.int/news-room/fact-sheets/detail/chronic-obstructive-pulmonary-disease-(copd) (cited 2022 Apr 14). (In Russ.).
  4. Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet. 2020;396(10258):1204-22.
  5. Mylnikova LA, Kamynina NN. Interagency programmatic approach to organize public health promotion events in Moscow. City HealthCare Journal. 2020;1(2):20-31. URL: https://doi.org/10.47619/2713-2617.zm.2020.v1i2;20-31 (In Russ.).
  6. Feiginova SI, Savina AA. Prevalence of risk factors for non-communicable diseases among the adult population of several administrative districts of Moscow before the COVID-19 pandemic. City Healthсare. 2021;2(4):71-83. doi: 10.47619/2713-2617.zm.2021.v2i4;71-83 (In Russ.).
  7. Sabgayda TP, Zubko AV, Semyonova VG. Changes in the structure of the death causes in the second year of the COVID-19 pandemic in Moscow. Social'nye aspekty zdorov'a naselenia / Social aspects of population health [serial online] 2021; 67(4):1. URL: http://vestnik.mednet.ru/content/view/1280/30/lang.ru/ (In Russ.).
  8. Demidova TYu, Volkova EI, Gritskevich EYu. Peculiarities of the COVID-19 course and consequences in overweight and obese patients. Lessons from the current pandemic. Obesity and metabolism. 2020;17(4):375-384. URL: https://doi.org/10.14341/omet12663. (In Russ.).
  9. Rusanova NE, Kamynina NN. Coronavirus and premature mortality from noncommunicable diseases in Russia. Narodonaselenie [Population]. 2021;24(3):123-134. doi: 10.19181/population.2021.24.3.10. (In Russ.).
  10. Artyukhov IP, Kapitonov VF, Senchenko AYu, Kapitonov FV. Morbidity of population in the conditions of active clinical examination. Siberian Medical Review. 2019;(2):110-6 (In Russ.). doi: 10.20333/2500136-2019-2-110-116. (In Russ.).
  11. Noncommunicable diseases – WHO Fact sheets [Online]. URL: https://www.who.int/news-room/fact-sheets/detail/noncommunicable-diseases (cited 2022 Apr 14).
  12. Grechushkina NA. Public health in Moscow in the context of the sustainable development goal “Good health and well-being”. City Healthсare. 2021;2(4):63-70. doi: 10.47619/2713-2617.zm.2021.v2i4;63-70 (In Russ.).
  13. Rabe KF, Watz H. Chronic obstructive pulmonary disease. Lancet. 2017 May 13;389(10082):1931-1940. doi: 10.1016/S0140-6736(17)31222-9. Epub 2017 May 11. PMID: 28513453.
  14. Lutskan IP, Savvina NV, Savvina AD, Uarova AV, Lazareva AA, Li IE, Nazarova KN. Comprehensive health examination of young athletes in the center as a stage of a health inspection at in-depth health check-up. Vestnik of North-Eastern Federal University. 2012;9(1):63-68 (In Russ.).
  15. Ishmurzin GP. The effect of training of copd patients and bronchial asthma on the frequency of exacerbations requiring emergency hospitalization. The Bulletin of Contemporary Clinical Medicine. 2015; 8 (Suppl. 1): 46-56 (In Russ.).
  16. Yudin AA, Ukhanova OP, Dzhabarova AA. Distantsionnyi monitoring patsientov s bronkhialnoi astmoi [Remote monitoring of patients with asthma]. Prioritetnye nauchnye napravleniia: ot teorii k praktike. 2016;(23):49-56 (In Russ.).
  17. Smirnova MI, Antipushina DN, Drapkina OM. Telemanagement technologies for patients with asthma (a review of scientific literature). Profilakticheskaya Meditsina. 2019;22(6):125‑132. URL: https://doi.org/10.17116//profmed201922061125. (In Russ.).
  18. Maslova OP, Vavilov AV. Concept development and business plan for the improving of medical institutions. Health and Education Millennium. 2016; 18(4):60-66 (In Russ.).
  19. Dyshite glubzhe [Breathe deeply] [Online]. Available from: https://ecomonitoring.tass.ru/ (cited 2022 Apr 14) (In Russ.).
  20. Mosecomonitoring [Online]. URL: https://mosecom.mos.ru/about-us/ (cited 2022 Apr 14). (In Russ.).
  21. Revich BA. Urban planning and public health: analytical review. Health Risk Analysis. 2022;(1):157-169. doi: 10.21668/health.risk/2022.1.17.eng. (In Russ.).

Файлы

Статистика

Просмотры аннотации: 6220
Просмотры XML: 26
Просмотры PDF: 665
Всего: 6911